BioSpace News Archive

Liberty Health Sciences Inc. announced that Sheri Cholodofsky has been appointed Chief Financial Officer, subject to Florida Department of Health approval.

The Ohio Mesothelioma Victims Center says, “Our top priority to see to it that a person anywhere in Ohio with recently diagnosed person with mesothelioma has on the spot access to some of the nation’s most experienced and skilled mesothelioma attorneys.

Enleofen Bio announced the publication of promising data from a preclinical study of a novel therapy targeting a severe form of fatty liver disease.

Genomic Testing Cooperative, LCA announced that data using its unique DNA and RNA profiling will be presented at the American Society of Clinical Oncology annual meeting.

Ng will further enable strategic engagements between biopharmaceutical and medical technology companies and health systems

Exicure, Inc., the pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic acid constructs, announced a presentation at TIDES: Oligonucleotide and Peptide Therapeutics, the world’s largest meeting to accelerate oligonucleotide and peptide products from early discovery to late-stage development and commercialization.

AirAvant Medical is proud to announce that its flagship product, the FDA cleared Bongo® Rx, is now available for patients requiring treatment of mild to moderate obstructive sleep apnea.

Anti-Interleukin 6 Monoclonal Antibody for Antibody-Mediated Kidney Transplant Rejection

Medicure Inc., a pharmaceutical company, will release financial results for the quarter ended March 31, 2019 on Monday, May 27, 2019.

Findings could expand number of patients who can receive alternative treatment to life-long use of blood thinners